{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "25517222",
  "DateCompleted": {
    "Year": "2015",
    "Month": "08",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "06",
    "Day": "25"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1097/QCO.0000000000000130"
    ],
    "Journal": {
      "ISSN": "1473-6527",
      "JournalIssue": {
        "Volume": "28",
        "Issue": "1",
        "PubDate": {
          "Year": "2015",
          "Month": "Feb"
        }
      },
      "Title": "Current opinion in infectious diseases",
      "ISOAbbreviation": "Curr Opin Infect Dis"
    },
    "ArticleTitle": "Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.",
    "Pagination": {
      "StartPage": "97",
      "EndPage": "105",
      "MedlinePgn": "97-105"
    },
    "Abstract": {
      "AbstractText": [
        "Recurrent urinary tract infection (rUTI) is a serious clinical problem, yet effective therapeutic options are limited, especially against multidrug-resistant uropathogens. In this review, we explore the development of a clinically relevant model of rUTI in previously infected mice and review recent developments in bladder innate immunity that may affect susceptibility to rUTI.",
        "Chronic bladder inflammation during prolonged bacterial cystitis in mice causes bladder mucosal remodelling that sensitizes the host to rUTI. Although constitutive defenses help prevent bacterial colonization of the urinary bladder, once infection occurs, induced cytokine and myeloid cell responses predominate and the balance of immune cell defense and bladder immunopathology is critical for determining disease outcome, in both na\u00efve and experienced mice. In particular, the maintenance of the epithelial barrier appears to be essential for preventing severe infection.",
        "The innate immune response plays a key role in determining susceptibility to rUTI. Future studies should be directed towards understanding how the innate immune response changes as a result of bladder mucosal remodelling in previously infected mice, and validating these findings in human clinical specimens. New therapeutics targeting the immune response should selectively target the induced innate responses that cause bladder immunopathology, while leaving protective defenses intact."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "aDepartment of Molecular Microbiology and Center for Women's Infectious Disease Research bDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri cDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA."
          }
        ],
        "LastName": "O'Brien",
        "ForeName": "Valerie P",
        "Initials": "VP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hannan",
        "ForeName": "Thomas J",
        "Initials": "TJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Schaeffer",
        "ForeName": "Anthony J",
        "Initials": "AJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hultgren",
        "ForeName": "Scott J",
        "Initials": "SJ"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 AI029549",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI048689",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AI48689",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI049950",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P50 DK064540",
        "Acronym": "DK",
        "Agency": "NIDDK NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AI49950",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AI95542",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "K08 AI083746",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "DK51406",
        "Acronym": "DK",
        "Agency": "NIDDK NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AI29549",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "DK64540",
        "Acronym": "DK",
        "Agency": "NIDDK NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U01 AI095542",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U01 AI095776",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U01AI095776",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R37 AI048689",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R37 AI029549",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 DK051406",
        "Acronym": "DK",
        "Agency": "NIDDK NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, U.S. Gov't, Non-P.H.S.",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Curr Opin Infect Dis",
    "NlmUniqueID": "8809878",
    "ISSNLinking": "0951-7375"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Models, Animal"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Susceptibility"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Escherichia coli"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology"
      ],
      "DescriptorName": "Escherichia coli Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunity, Innate"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology"
      ],
      "DescriptorName": "Mucous Membrane"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [
        "microbiology",
        "pathology"
      ],
      "DescriptorName": "Urinary Bladder"
    },
    {
      "QualifierName": [
        "immunology",
        "microbiology",
        "pathology"
      ],
      "DescriptorName": "Urinary Tract Infections"
    }
  ],
  "CoiStatement": "<b>Conflicts of interest</b>. The authors declare that there are no conflicts of interest."
}